GSA Capital Partners »

Rapt Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $508k 20k 24.86
2023-09-30 $510k 31k 16.60
2023-06-30 $657k 35k 18.70
2023-03-31 $557k 30k 18.35
2022-09-30 $912k 38k 24.07
2022-06-30 $203k 11k 18.25
2022-03-31 $416k 19k 21.99
2021-12-31 $323k 8.8k 36.77
2021-09-30 $1.0M 33k 31.06